![Curt Bradshaw](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Curt Bradshaw
Plus aucun poste en cours
Profil
Curt William Bradshaw was the founder of Solstice Biologics LLC, founded in 2012, where the titles held included Secretary, Treasurer & Director from 2012 to 2018.
Dr. Bradshaw was the founder of Tallac Therapeutics, Inc., founded in 2018, where the titles held included President, Chief Scientific Officer & Director from 2018 to 2019.
Dr. Bradshaw currently holds the position of Chief Scientific Officer at Sirius Therapeutics since 2021.
Dr. Bradshaw also currently holds the position of Vice President-Research & Development at CovX Research LLC since 2002.
Former positions include Principal at Abbott Laboratories, Principal at Ligand Pharmaceuticals, Inc., Chief Scientific Officer at Arrowhead Pharmaceuticals, Inc. from 2019 to 2020, Principal at Pfizer Asia, Chief Scientific Officer at NeuBase Therapeutics, Inc. from 2020 to 2021, and Chief Scientific Officer at Traversa Therapeutics, Inc. from 2011 to 2012.
Dr. Bradshaw earned a doctorate degree from Texas A&M University in 1992.
Postes actifs de Curt Bradshaw
| Sociétés | Poste | Début |
|---|---|---|
CovX Research LLC
 CovX Research LLC BiotechnologyHealth Technology Manufactures biotherapeutics and medical products | Directeur Technique/Scientifique/R&D | 01/09/2002 |
Anciens postes connus de Curt Bradshaw
| Sociétés | Poste | Fin |
|---|---|---|
| NEUBASE THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/06/2021 |
| ARROWHEAD PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 01/11/2020 |
Tallac Therapeutics, Inc.
 Tallac Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development of immunomodulation polynucleotides | Fondateur | 01/10/2019 |
Solstice Biologics LLC
 Solstice Biologics LLC Pharmaceuticals: MajorHealth Technology Develops cell-permeable RNAi pro-drugs | Fondateur | 01/01/2018 |
Traversa Therapeutics, Inc.
 Traversa Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in discovery, development , and commercialization of RNAi delivery technologies | Directeur Technique/Scientifique/R&D | 19/12/2012 |
Formation de Curt Bradshaw
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
89
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Abbott Laboratories
 Abbott Laboratories Medical SpecialtiesHealth Technology Develops and manufactures medical devices, diagnostic systems, pharmaceuticals & nutritional products | Health Technology |
Ligand Pharmaceuticals, Inc.
 Ligand Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and sells drug development technologies | Health Technology |
Arrowhead Pharmaceuticals, Inc.
 Arrowhead Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops novel drugs to treat intractable diseases | Health Technology |
Solstice Biologics LLC
Solstice Biologics LLC Pharmaceuticals: MajorHealth Technology Develops cell-permeable RNAi pro-drugs | Health Technology |
Texas A&M University
 Texas A&M University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CovX Research LLC
CovX Research LLC BiotechnologyHealth Technology Manufactures biotherapeutics and medical products | Health Technology |
Traversa Therapeutics, Inc.
Traversa Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in discovery, development , and commercialization of RNAi delivery technologies | Commercial Services |
Pfizer Asia | |
NeuBase Therapeutics, Inc.
 NeuBase Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company, which engages in the development of drugs for patients with genetic neurological disorders | Health Technology |
Tallac Therapeutics, Inc.
Tallac Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development of immunomodulation polynucleotides | Health Technology |
